Ultan Mcdermott

2017-present Chief Scientist, Oncology, AstraZeneca, UK 2017-present Honorary Faculty, Wellcome Sanger Institute, UK 2010-2017 Group Leader and Faculty, Wellcome Sanger Institute, UK 2009-present Honorary Consultant Medical Oncologist, Addenbrooke’s Hospital, Cambridge, UK 2010-2016 CRUK Clinician Scientist, Wellcome Sanger Institute, UK 2009-2010 Clinical Research Fellow, Wellcome Sanger Institute, UK 2005-2008 Postdoctoral Research Fellow, MGH Cancer Center and Harvard Medical School, Boston, USA 2001-2005 PhD in Dept of Oncology, Queen’s University Belfast 1994-2001 Junior medical positions and Medical Oncology Specialist Registrar